Furthermore, the bi-specific inhibitor reduced the viability of SCC47 head and neck cancer cells by virtue of enhanced immune cell cytotoxicity conferred by inhibition of PDL1 and VEGF. The gene discussed is CD274; the disease is head and neck cancer.